Skip to content

Creatinine2

by Abbott Ireland Diagnostics Division

510(k) K210452

Creatinine2 is a medical device (FDA Class II; FDA product code CGX, Alkaline Picrate, Colorimetry, Creatinine) made by Abbott Ireland Diagnostics Division, cleared under FDA 510(k) K210452 on 22 Mar 2022, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK210452 Date22 Mar 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 Feb 2021
FDA decision
22 Mar 2022 (Substantially Equivalent)
FDA review time
399 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K210452 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CGX
Device class
Class II
Regulation
21 CFR Part 862.1225
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code CGX (Alkaline Picrate, Colorimetry, Creatinine).

Other devices from Abbott Ireland Diagnostics Division

See all devices from Abbott Ireland Diagnostics Division →